484 Participants Needed

Personalized Activation Letter for High Blood Pressure

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The BP Activate Study aims to assess the effectiveness of the BP Report letter with personalized BP medication recommendations, compared with Control letters and no intervention, at shortening time to appointment, time to visit, time to medication change, and time to achievement of BP goal.

Research Team

MP

Mark Pletcher, MD MPH

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for primary care patients with high blood pressure (SBP>140 or DBP>90) seen in a general internal medicine clinic within the last 2 years, where medication intensification is needed. It's not for those who don't speak English or whose provider opts them out.

Inclusion Criteria

Lowest SBP>140 or lowest DBP>90 at last visit in general internal medicine clinic
Patient is a primary care patient of a clinician in a general internal medicine clinic who has agreed to have their patients participate in the study
Last visit in general internal medicine clinic was < 2 years ago
See 1 more

Exclusion Criteria

Primary language is not English
Patient's provider indicates (through an active opt-out process) that they do not want the patient to receive a BP Activate letter

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive either the BP Activate Report Letter, Control Letter, or no intervention

6 months
Participants are encouraged to schedule a visit with their provider

Follow-up

Participants are monitored for time to medication change or BP control

6 months

Treatment Details

Interventions

  • BP Activate Letter
  • Control Letter
Trial Overview The study compares the effectiveness of personalized BP Report letters recommending medication changes to Control letters and no intervention, measuring how quickly patients schedule appointments, visit clinics, change medications, and reach their BP goals.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: BP Activate LetterExperimental Treatment1 Intervention
Participants in the BP Activate Letter arm will receive a BP Report letter that includes computerized algorithm recommendations for medication changes they should discuss with their clinician.
Group II: Control LetterActive Control1 Intervention
Participants in the Control Letter arm will receive a Control letter suggesting they talk to their clinician about their blood pressure (without BP history or specific medication recommendations).
Group III: Usual CareActive Control1 Intervention
Participants in the Usual Care arm will not receive any letter or any other intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security